Novo Nordisk’s GLP-1 agonist Ozempic has shown efficacy in yet another indication, achieving a 24% reduction in kidney disease-related events in people with type 2 diabetes and chronic kidney disease ...
Learn the location of all upgrade components in the Mass Production Array sector in Pragmata, the city-themed zone.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results